These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 16257840)
21. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy. Abaza R; Diaz LK; Laskin WB; Pins MR J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199 [TBL] [Abstract][Full Text] [Related]
22. Correlation of DNA ploidy and histologic diagnosis from prostate core-needle biopsies: is DNA ploidy more sensitive than histology for the diagnosis of carcinoma in small specimens? Lo J; Kerns BJ; Amling CL; Robertson CN; Layfield LJ J Surg Oncol; 1996 Sep; 63(1):41-5. PubMed ID: 8841465 [TBL] [Abstract][Full Text] [Related]
23. Prognostic value of DNA ploidy status in patients with rectal cancer. Berczi C; Bocsi J; Bartha I; Math J; Balazs G Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986 [TBL] [Abstract][Full Text] [Related]
24. Near tetraploid prostate carcinoma. Methodologic and prognostic aspects. Forsslund G; Nilsson B; Zetterberg A Cancer; 1996 Oct; 78(8):1748-55. PubMed ID: 8859188 [TBL] [Abstract][Full Text] [Related]
25. [Comparison between nuclear DNA and histologic grade of prostatic carcinoma]. Zattoni F; Prayer Galetti T; Vianello F; Bertoldin R; Panozzo M; Blandamura S; Costantin G J Urol (Paris); 1992; 98(4):192-5. PubMed ID: 1284300 [TBL] [Abstract][Full Text] [Related]
26. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade. Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706 [TBL] [Abstract][Full Text] [Related]
27. Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. Schröder F; Tribukait B; Böcking A; DeVere White R; Koss L; Lieber M; Stenkvist B; Zetterberg A Scand J Urol Nephrol Suppl; 1994; 162():51-63; discussion 15-27. PubMed ID: 7529429 [TBL] [Abstract][Full Text] [Related]
28. Percent tumor involvement and risk of biochemical progression after radical prostatectomy. Rampersaud EN; Sun L; Moul JW; Madden J; Freedland SJ J Urol; 2008 Aug; 180(2):571-6; discussion 576. PubMed ID: 18554662 [TBL] [Abstract][Full Text] [Related]
29. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy. Sankin A; Tareen B; Lepor H Prostate Cancer Prostatic Dis; 2009; 12(2):204-8. PubMed ID: 19238170 [TBL] [Abstract][Full Text] [Related]
30. Caveats in the estimation of DNA-ploidy in paraffin embedded specimens of primary prostate cancer and lymph node metastases by flow and image cytometry. Berner A; Danielsen HE; Juul NO; Juul ME; Pettersen EO; Reith A; Nesland JM; Fosså SD Anal Cell Pathol; 1993 Nov; 5(6):339-52. PubMed ID: 8305330 [TBL] [Abstract][Full Text] [Related]
31. PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance. Nakanishi H; Groskopf J; Fritsche HA; Bhadkamkar V; Blase A; Kumar SV; Davis JW; Troncoso P; Rittenhouse H; Babaian RJ J Urol; 2008 May; 179(5):1804-9; discussion 1809-10. PubMed ID: 18353398 [TBL] [Abstract][Full Text] [Related]
32. Can ploidy of prostate carcinoma diagnosed on needle biopsy predict radical prostatectomy stage and grade? Brinker DA; Ross JS; Tran TA; Jones DM; Epstein JI J Urol; 1999 Dec; 162(6):2036-9. PubMed ID: 10569563 [TBL] [Abstract][Full Text] [Related]
34. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers. Furuya T; Uchiyama T; Murakami T; Adachi A; Kawauchi S; Oga A; Hirano T; Sasaki K Clin Cancer Res; 2000 Jul; 6(7):2815-20. PubMed ID: 10914729 [TBL] [Abstract][Full Text] [Related]
35. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
36. Use of effective core volume obtained from transrectal biopsies for predicting target tumor volume. Kobayashi T; Mitsumori K; Nishizawa K; Kawahara T; Ogura K; Ide Y Urology; 2005 Oct; 66(4):794-8. PubMed ID: 16230140 [TBL] [Abstract][Full Text] [Related]
37. Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer. Nativ O; Umehara T; Colvard DS; Therneau TM; Farrow GM; Spelsberg TC; Lieber MM Eur Urol; 1997; 32(1):96-9. PubMed ID: 9266239 [TBL] [Abstract][Full Text] [Related]
38. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy. Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048 [TBL] [Abstract][Full Text] [Related]
39. Significance of abnormal diploid DNA histograms in localized prostate cancer and adjacent benign prostatic tissue. Deitch AD; Miller GJ; deVere White RW Cancer; 1993 Sep; 72(5):1692-700. PubMed ID: 7688657 [TBL] [Abstract][Full Text] [Related]
40. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database. Freedland SJ; Hotaling JM; Fitzsimons NJ; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL Eur Urol; 2008 Apr; 53(4):758-64; discussion 765-6. PubMed ID: 17868976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]